Global Transmucosal Drug Delivery Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 3/1/2023
- NO OF PAGES
- 256
- CATEGORY
- Healthcare & Life Sciences
Transmucosal Drug Delivery market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain which gives brief strategy of market growth during the forecast period. It also gives in-depth insights on SWOT and PESTLE analysis based on industry segmentations and regional developments.
Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Transmucosal Drug Delivery market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Transmucosal Drug Delivery manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Transmucosal Drug Delivery market covering all its essential aspects.
Global Transmucosal Drug Delivery Market: Segmentations
Global Transmucosal Drug Delivery Market: By Types
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Global Transmucosal Drug Delivery Market: By Applications
Hospital
Clinic
Others
Global Transmucosal Drug Delivery Market: Major Players
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
Global Transmucosal Drug Delivery Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Transmucosal Drug Delivery market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Transmucosal Drug Delivery would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Transmucosal Drug Delivery Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Base Year: 2023Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Transmucosal Drug Delivery market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.
Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Transmucosal Drug Delivery manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Transmucosal Drug Delivery market covering all its essential aspects.
Global Transmucosal Drug Delivery Market: Segmentations
Global Transmucosal Drug Delivery Market: By Types
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Global Transmucosal Drug Delivery Market: By Applications
Hospital
Clinic
Others
Global Transmucosal Drug Delivery Market: Major Players
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
Global Transmucosal Drug Delivery Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Transmucosal Drug Delivery market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Transmucosal Drug Delivery would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Transmucosal Drug Delivery Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1 Market Overview
1.1 Product Overview and Scope of Transmucosal Drug Delivery
1.2 Classification of Transmucosal Drug Delivery by Type
1.2.1 Overview: Global Transmucosal Drug Delivery Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Transmucosal Drug Delivery Revenue Market Share by Type in 2022
1.2.3 Passive Transdermal Drug Delivery
1.2.4 Active Transdermal Drug Delivery
1.3 Global Transmucosal Drug Delivery Market by Application
1.3.1 Overview: Global Transmucosal Drug Delivery Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Transmucosal Drug Delivery Market Size & Forecast
1.5 Global Transmucosal Drug Delivery Market Size and Forecast by Region
1.5.1 Global Transmucosal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Transmucosal Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.4 Europe Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.6 South America Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Transmucosal Drug Delivery Market Drivers
1.6.2 Transmucosal Drug Delivery Market Restraints
1.6.3 Transmucosal Drug Delivery Trends Analysis
2 Company Profiles
2.1 3M Pharmaceuticals
2.1.1 3M Pharmaceuticals Details
2.1.2 3M Pharmaceuticals Major Business
2.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Product and Solutions
2.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 3M Pharmaceuticals Recent Developments and Future Plans
2.2 Acrux Limited
2.2.1 Acrux Limited Details
2.2.2 Acrux Limited Major Business
2.2.3 Acrux Limited Transmucosal Drug Delivery Product and Solutions
2.2.4 Acrux Limited Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Acrux Limited Recent Developments and Future Plans
2.3 ALZA Corporation
2.3.1 ALZA Corporation Details
2.3.2 ALZA Corporation Major Business
2.3.3 ALZA Corporation Transmucosal Drug Delivery Product and Solutions
2.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 ALZA Corporation Recent Developments and Future Plans
2.4 Antares Pharma, Inc.
2.4.1 Antares Pharma, Inc. Details
2.4.2 Antares Pharma, Inc. Major Business
2.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Product and Solutions
2.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Antares Pharma, Inc. Recent Developments and Future Plans
2.5 Apricus BioSciences, Inc
2.5.1 Apricus BioSciences, Inc Details
2.5.2 Apricus BioSciences, Inc Major Business
2.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Product and Solutions
2.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Apricus BioSciences, Inc Recent Developments and Future Plans
2.6 Aveva Drug Delivery Systems
2.6.1 Aveva Drug Delivery Systems Details
2.6.2 Aveva Drug Delivery Systems Major Business
2.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Product and Solutions
2.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Aveva Drug Delivery Systems Recent Developments and Future Plans
2.7 Corium International, Inc
2.7.1 Corium International, Inc Details
2.7.2 Corium International, Inc Major Business
2.7.3 Corium International, Inc Transmucosal Drug Delivery Product and Solutions
2.7.4 Corium International, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Corium International, Inc Recent Developments and Future Plans
2.8 DURECT Corporation
2.8.1 DURECT Corporation Details
2.8.2 DURECT Corporation Major Business
2.8.3 DURECT Corporation Transmucosal Drug Delivery Product and Solutions
2.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 DURECT Corporation Recent Developments and Future Plans
2.9 Generex Biotechnology Corporation
2.9.1 Generex Biotechnology Corporation Details
2.9.2 Generex Biotechnology Corporation Major Business
2.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Product and Solutions
2.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Generex Biotechnology Corporation Recent Developments and Future Plans
2.10 Inovio Pharmaceuticals, Inc.
2.10.1 Inovio Pharmaceuticals, Inc. Details
2.10.2 Inovio Pharmaceuticals, Inc. Major Business
2.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
2.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Inovio Pharmaceuticals, Inc. Recent Developments and Future Plans
2.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
2.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Details
2.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Major Business
2.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product and Solutions
2.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments and Future Plans
2.12 MedPharm LTD
2.12.1 MedPharm LTD Details
2.12.2 MedPharm LTD Major Business
2.12.3 MedPharm LTD Transmucosal Drug Delivery Product and Solutions
2.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 MedPharm LTD Recent Developments and Future Plans
2.13 Mylan, Inc.
2.13.1 Mylan, Inc. Details
2.13.2 Mylan, Inc. Major Business
2.13.3 Mylan, Inc. Transmucosal Drug Delivery Product and Solutions
2.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Mylan, Inc. Recent Developments and Future Plans
2.14 Nemaura Pharma Ltd
2.14.1 Nemaura Pharma Ltd Details
2.14.2 Nemaura Pharma Ltd Major Business
2.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Product and Solutions
2.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Nemaura Pharma Ltd Recent Developments and Future Plans
2.15 Nitto Denko Corporation
2.15.1 Nitto Denko Corporation Details
2.15.2 Nitto Denko Corporation Major Business
2.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Product and Solutions
2.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Nitto Denko Corporation Recent Developments and Future Plans
2.16 Noven Pharmaceuticals, Inc.
2.16.1 Noven Pharmaceuticals, Inc. Details
2.16.2 Noven Pharmaceuticals, Inc. Major Business
2.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
2.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Noven Pharmaceuticals, Inc. Recent Developments and Future Plans
2.17 Pantec Biosolutions AG
2.17.1 Pantec Biosolutions AG Details
2.17.2 Pantec Biosolutions AG Major Business
2.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Product and Solutions
2.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Pantec Biosolutions AG Recent Developments and Future Plans
2.18 Tapemark
2.18.1 Tapemark Details
2.18.2 Tapemark Major Business
2.18.3 Tapemark Transmucosal Drug Delivery Product and Solutions
2.18.4 Tapemark Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Tapemark Recent Developments and Future Plans
2.19 tesa Labtec GmbH
2.19.1 tesa Labtec GmbH Details
2.19.2 tesa Labtec GmbH Major Business
2.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Product and Solutions
2.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 tesa Labtec GmbH Recent Developments and Future Plans
2.20 TEVA Pharmaceutical Industries Ltd.
2.20.1 TEVA Pharmaceutical Industries Ltd. Details
2.20.2 TEVA Pharmaceutical Industries Ltd. Major Business
2.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product and Solutions
2.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 TEVA Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.21 Zosano Pharma
2.21.1 Zosano Pharma Details
2.21.2 Zosano Pharma Major Business
2.21.3 Zosano Pharma Transmucosal Drug Delivery Product and Solutions
2.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Zosano Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transmucosal Drug Delivery Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Transmucosal Drug Delivery Players Market Share
3.2.2 Top 10 Transmucosal Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Transmucosal Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Transmucosal Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Transmucosal Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Transmucosal Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Transmucosal Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Transmucosal Drug Delivery Revenue by Type (2017-2032)
6.2 North America Transmucosal Drug Delivery Revenue by Application (2017-2032)
6.3 North America Transmucosal Drug Delivery Market Size by Country
6.3.1 North America Transmucosal Drug Delivery Revenue by Country (2017-2032)
6.3.2 United States Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
6.3.3 Canada Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
6.3.4 Mexico Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Transmucosal Drug Delivery Revenue by Type (2017-2032)
7.2 Europe Transmucosal Drug Delivery Revenue by Application (2017-2032)
7.3 Europe Transmucosal Drug Delivery Market Size by Country
7.3.1 Europe Transmucosal Drug Delivery Revenue by Country (2017-2032)
7.3.2 Germany Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.3 France Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.5 Russia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.6 Italy Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Transmucosal Drug Delivery Revenue by Type (2017-2032)
8.2 Asia-Pacific Transmucosal Drug Delivery Revenue by Application (2017-2032)
8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Transmucosal Drug Delivery Revenue by Region (2017-2032)
8.3.2 China Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.3 Japan Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.4 South Korea Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.5 India Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.7 Australia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Transmucosal Drug Delivery Revenue by Type (2017-2032)
9.2 South America Transmucosal Drug Delivery Revenue by Application (2017-2032)
9.3 South America Transmucosal Drug Delivery Market Size by Country
9.3.1 South America Transmucosal Drug Delivery Revenue by Country (2017-2032)
9.3.2 Brazil Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
9.3.3 Argentina Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Transmucosal Drug Delivery Revenue by Type (2017-2032)
10.2 Middle East & Africa Transmucosal Drug Delivery Revenue by Application (2017-2032)
10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Transmucosal Drug Delivery Revenue by Country (2017-2032)
10.3.2 Turkey Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
10.3.4 UAE Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Transmucosal Drug Delivery
1.2 Classification of Transmucosal Drug Delivery by Type
1.2.1 Overview: Global Transmucosal Drug Delivery Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Transmucosal Drug Delivery Revenue Market Share by Type in 2022
1.2.3 Passive Transdermal Drug Delivery
1.2.4 Active Transdermal Drug Delivery
1.3 Global Transmucosal Drug Delivery Market by Application
1.3.1 Overview: Global Transmucosal Drug Delivery Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Transmucosal Drug Delivery Market Size & Forecast
1.5 Global Transmucosal Drug Delivery Market Size and Forecast by Region
1.5.1 Global Transmucosal Drug Delivery Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Transmucosal Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.4 Europe Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.6 South America Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Transmucosal Drug Delivery Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Transmucosal Drug Delivery Market Drivers
1.6.2 Transmucosal Drug Delivery Market Restraints
1.6.3 Transmucosal Drug Delivery Trends Analysis
2 Company Profiles
2.1 3M Pharmaceuticals
2.1.1 3M Pharmaceuticals Details
2.1.2 3M Pharmaceuticals Major Business
2.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Product and Solutions
2.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 3M Pharmaceuticals Recent Developments and Future Plans
2.2 Acrux Limited
2.2.1 Acrux Limited Details
2.2.2 Acrux Limited Major Business
2.2.3 Acrux Limited Transmucosal Drug Delivery Product and Solutions
2.2.4 Acrux Limited Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Acrux Limited Recent Developments and Future Plans
2.3 ALZA Corporation
2.3.1 ALZA Corporation Details
2.3.2 ALZA Corporation Major Business
2.3.3 ALZA Corporation Transmucosal Drug Delivery Product and Solutions
2.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 ALZA Corporation Recent Developments and Future Plans
2.4 Antares Pharma, Inc.
2.4.1 Antares Pharma, Inc. Details
2.4.2 Antares Pharma, Inc. Major Business
2.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Product and Solutions
2.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Antares Pharma, Inc. Recent Developments and Future Plans
2.5 Apricus BioSciences, Inc
2.5.1 Apricus BioSciences, Inc Details
2.5.2 Apricus BioSciences, Inc Major Business
2.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Product and Solutions
2.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Apricus BioSciences, Inc Recent Developments and Future Plans
2.6 Aveva Drug Delivery Systems
2.6.1 Aveva Drug Delivery Systems Details
2.6.2 Aveva Drug Delivery Systems Major Business
2.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Product and Solutions
2.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Aveva Drug Delivery Systems Recent Developments and Future Plans
2.7 Corium International, Inc
2.7.1 Corium International, Inc Details
2.7.2 Corium International, Inc Major Business
2.7.3 Corium International, Inc Transmucosal Drug Delivery Product and Solutions
2.7.4 Corium International, Inc Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Corium International, Inc Recent Developments and Future Plans
2.8 DURECT Corporation
2.8.1 DURECT Corporation Details
2.8.2 DURECT Corporation Major Business
2.8.3 DURECT Corporation Transmucosal Drug Delivery Product and Solutions
2.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 DURECT Corporation Recent Developments and Future Plans
2.9 Generex Biotechnology Corporation
2.9.1 Generex Biotechnology Corporation Details
2.9.2 Generex Biotechnology Corporation Major Business
2.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Product and Solutions
2.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 Generex Biotechnology Corporation Recent Developments and Future Plans
2.10 Inovio Pharmaceuticals, Inc.
2.10.1 Inovio Pharmaceuticals, Inc. Details
2.10.2 Inovio Pharmaceuticals, Inc. Major Business
2.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
2.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 Inovio Pharmaceuticals, Inc. Recent Developments and Future Plans
2.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
2.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Details
2.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Major Business
2.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product and Solutions
2.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Developments and Future Plans
2.12 MedPharm LTD
2.12.1 MedPharm LTD Details
2.12.2 MedPharm LTD Major Business
2.12.3 MedPharm LTD Transmucosal Drug Delivery Product and Solutions
2.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.12.5 MedPharm LTD Recent Developments and Future Plans
2.13 Mylan, Inc.
2.13.1 Mylan, Inc. Details
2.13.2 Mylan, Inc. Major Business
2.13.3 Mylan, Inc. Transmucosal Drug Delivery Product and Solutions
2.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.13.5 Mylan, Inc. Recent Developments and Future Plans
2.14 Nemaura Pharma Ltd
2.14.1 Nemaura Pharma Ltd Details
2.14.2 Nemaura Pharma Ltd Major Business
2.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Product and Solutions
2.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.14.5 Nemaura Pharma Ltd Recent Developments and Future Plans
2.15 Nitto Denko Corporation
2.15.1 Nitto Denko Corporation Details
2.15.2 Nitto Denko Corporation Major Business
2.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Product and Solutions
2.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.15.5 Nitto Denko Corporation Recent Developments and Future Plans
2.16 Noven Pharmaceuticals, Inc.
2.16.1 Noven Pharmaceuticals, Inc. Details
2.16.2 Noven Pharmaceuticals, Inc. Major Business
2.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product and Solutions
2.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.16.5 Noven Pharmaceuticals, Inc. Recent Developments and Future Plans
2.17 Pantec Biosolutions AG
2.17.1 Pantec Biosolutions AG Details
2.17.2 Pantec Biosolutions AG Major Business
2.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Product and Solutions
2.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.17.5 Pantec Biosolutions AG Recent Developments and Future Plans
2.18 Tapemark
2.18.1 Tapemark Details
2.18.2 Tapemark Major Business
2.18.3 Tapemark Transmucosal Drug Delivery Product and Solutions
2.18.4 Tapemark Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.18.5 Tapemark Recent Developments and Future Plans
2.19 tesa Labtec GmbH
2.19.1 tesa Labtec GmbH Details
2.19.2 tesa Labtec GmbH Major Business
2.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Product and Solutions
2.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.19.5 tesa Labtec GmbH Recent Developments and Future Plans
2.20 TEVA Pharmaceutical Industries Ltd.
2.20.1 TEVA Pharmaceutical Industries Ltd. Details
2.20.2 TEVA Pharmaceutical Industries Ltd. Major Business
2.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product and Solutions
2.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.20.5 TEVA Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.21 Zosano Pharma
2.21.1 Zosano Pharma Details
2.21.2 Zosano Pharma Major Business
2.21.3 Zosano Pharma Transmucosal Drug Delivery Product and Solutions
2.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue, Gross Margin and Market Share (2017-2022)
2.21.5 Zosano Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transmucosal Drug Delivery Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Transmucosal Drug Delivery Players Market Share
3.2.2 Top 10 Transmucosal Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Transmucosal Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Transmucosal Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Transmucosal Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Transmucosal Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Transmucosal Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Transmucosal Drug Delivery Revenue by Type (2017-2032)
6.2 North America Transmucosal Drug Delivery Revenue by Application (2017-2032)
6.3 North America Transmucosal Drug Delivery Market Size by Country
6.3.1 North America Transmucosal Drug Delivery Revenue by Country (2017-2032)
6.3.2 United States Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
6.3.3 Canada Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
6.3.4 Mexico Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Transmucosal Drug Delivery Revenue by Type (2017-2032)
7.2 Europe Transmucosal Drug Delivery Revenue by Application (2017-2032)
7.3 Europe Transmucosal Drug Delivery Market Size by Country
7.3.1 Europe Transmucosal Drug Delivery Revenue by Country (2017-2032)
7.3.2 Germany Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.3 France Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.5 Russia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
7.3.6 Italy Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Transmucosal Drug Delivery Revenue by Type (2017-2032)
8.2 Asia-Pacific Transmucosal Drug Delivery Revenue by Application (2017-2032)
8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Transmucosal Drug Delivery Revenue by Region (2017-2032)
8.3.2 China Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.3 Japan Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.4 South Korea Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.5 India Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
8.3.7 Australia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Transmucosal Drug Delivery Revenue by Type (2017-2032)
9.2 South America Transmucosal Drug Delivery Revenue by Application (2017-2032)
9.3 South America Transmucosal Drug Delivery Market Size by Country
9.3.1 South America Transmucosal Drug Delivery Revenue by Country (2017-2032)
9.3.2 Brazil Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
9.3.3 Argentina Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Transmucosal Drug Delivery Revenue by Type (2017-2032)
10.2 Middle East & Africa Transmucosal Drug Delivery Revenue by Application (2017-2032)
10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Transmucosal Drug Delivery Revenue by Country (2017-2032)
10.3.2 Turkey Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
10.3.4 UAE Transmucosal Drug Delivery Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI